ORI Healthcare Fund L.P.

ORI Fund, a US $200 million venture capital fund, focuses on investing in innovative companies with disruptive technologies in the healthcare industry globally. The fund is founded by Ms. Simone (Hong Fang) Song, former investment banker and head of China Healthcare at Goldman Sachs. The team consists mostly of former Goldman Sachs bankers and healthcare scientists. *

	Start	2016-10-06 existent
	Industry	finance

	City	n. a.
		Address record changed: 2016-10-07

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	200,000,000 (funds, managed (2016) 2016-10-05)

		* Document for »About Section«:

		Record changed: 2019-07-13

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for ORI Healthcare Fund L.P.

[1] Orchard Therapeutics Ltd.. (12/20/17). "Press Release: Orchard Therapeutics Announces $110m Series B Financing to Advance Transformative Gene Therapy Pipeline". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)